Two Hands Ultherapy Prime & Aesthetic Lifting Clinic in Gangnam, Seoul · 1:1 Physician Care
Ultherapy & Sofwave Specialized Clinic · Gangnam-daero
en-US
Clinical Guide
New M-Cell at Maison de M: Autologous Blood Therapy
A neutral guide to New M-Cell Korea: an autologous blood-derived regenerative treatment in Seoul, its FDA status, risks and consultation steps.
Schedule a ConsultationNew M-Cell at Maison de M: Autologous Blood Therapy
Medically reviewed by Dr. Choi Chang Won, Chief Medical Director, Maison de M Clinic · Last updated July 2026
Patients researching New M-Cell Korea are usually looking for information on a specific type of service: an autologous, blood-derived regenerative treatment offered at Maison de M Clinic in Seoul, South Korea. "Autologous" simply means the biological material comes from your own body rather than a donor. This article explains, in neutral terms, what New M-Cell is, how it is described by the clinic, and how it is processed. Just as importantly, it sets out what the regulatory status of such treatments actually means, including a clear distinction between a device that may be cleared by the U.S. Food and Drug Administration (FDA) and a therapy being "FDA-approved" for effectiveness. Regenerative and stem-cell-adjacent treatments carry particular considerations, and the goal here is to help you ask informed questions rather than to make any promise about outcomes.
What Is New M-Cell?
According to Maison de M Clinic, New M-Cell (described as an autologous blood-cell regenerative therapy) is a treatment that uses cells and biologically active components obtained from the patient's own blood. The clinic states that the sample is processed on the same day, without laboratory cell culture, and then used as part of a regenerative treatment protocol. It is positioned by the clinic as a regenerative medicine service intended to support the body's natural processes, using minimally manipulated material derived from the patient's own blood.
In broad terms, New M-Cell belongs to the same general family as other autologous blood-derived approaches, such as platelet-rich plasma (PRP). PRP, for context, is a concentrated preparation made from a patient's own blood; the published literature describes it as containing platelets that release growth factors studied in various dermatologic applications. New M-Cell is the clinic's own protocol rather than PRP itself, but this broader category is useful background when discussing what the treatment is and is not.
Because the material is the patient's own, one commonly cited practical point is a reduced risk of immune incompatibility associated with autologous material. This is a general property of using one's own tissue and is not, by itself, a statement about effectiveness.

How the Treatment Is Performed
Maison de M Clinic describes New M-Cell as a same-day treatment. A representative sequence is:
- Medical consultation and eligibility assessment, including review of your medical history, current medications, allergies and treatment goals.
- Blood collection from the patient.
- Same-day processing of the sample using the clinic's protocol, without cell culture (described as minimal manipulation).
- Administration of the prepared regenerative blood-cell product according to the planned treatment.
- Post-treatment observation before discharge.
The clinic notes that discomfort is usually limited to the blood draw and the injection, and that local anesthesia may be used depending on the treatment area. General anesthesia is not typically described for this service. Because the protocol does not require laboratory cell culture, extended waiting periods between collection and administration are not needed. Suitability, the number of sessions and all specifics are determined individually by the treating physician; you can arrange an assessment through the clinic's contact page.
Understanding the FDA Status: Device Versus Therapy
This is the most important section to read carefully, because the regulatory language around regenerative treatments is easy to misread.
Maison de M Clinic states that New M-Cell processing uses an FDA 510(k)-cleared device. It is essential to understand what that does and does not mean:
- A 510(k) clearance applies to a medical device. It indicates the FDA has determined the device is substantially equivalent to a legally marketed device for its intended use (for example, a system used to process blood). It is a clearance of the equipment.
- A 510(k)-cleared device does not mean the regenerative therapy performed with it is FDA-approved for effectiveness. Approval of a therapy for efficacy is a separate, higher regulatory bar that these treatments generally have not met.
Stated plainly: autologous blood-derived regenerative aesthetic treatments are, as a category, generally not U.S.-FDA-approved for effectiveness. The clearance of a processing device is a statement about the equipment, not a validation of clinical benefit for any specific indication.
The FDA has issued a consumer alert about regenerative medicine products, including stem cell and exosome products, cautioning that some products are marketed without the agency's approval and may not have been shown to be safe or effective. The FDA has also published a patient and consumer warning about the potential serious risks of using unapproved products derived from human cells or tissues. For helpful comparison, even FDA-approved products in aesthetics, such as dermal fillers, are regulated as medical devices with defined intended uses and documented risks, which underscores how specific regulatory status is to each product and use.
Consistent with this framing, Maison de M Clinic's own stated position is that New M-Cell is offered as an autologous regenerative therapy using minimally manipulated blood-derived cells prepared without cell culture, and that no guarantee of therapeutic outcome or disease-specific benefit is made. All recommendations are individualized following physician assessment. This article makes no efficacy, disease-treatment or guaranteed-outcome claims, and you should be cautious of any source that does.
Who May Be Considered — and Who May Not
The clinic describes New M-Cell as potentially appropriate for individuals seeking an autologous regenerative treatment using their own blood-derived components, with suitability determined only after a comprehensive medical consultation. During that consultation, a physician reviews your medical history, current health status and goals to develop an individualized plan.
Certain individuals may not be suitable or may need to postpone treatment. The clinic notes that people with active infections, uncontrolled medical conditions, significant blood disorders, or other contraindications identified during evaluation may not be candidates. Final eligibility rests with the treating physician after assessment. Because every situation is different, candidacy cannot be determined from an article; it requires an individual clinical evaluation.
Realistic Expectations, Results and Recovery
Regenerative treatments are described as working gradually. Maison de M Clinic notes that the onset and duration of any response vary depending on the treatment indication, the patient's clinical condition and individual biological response, and that improvements, where they occur, may develop over time. The clinic is explicit that results and longevity differ among patients and that no specific therapeutic outcome can be guaranteed. It is reasonable to expect the physician to discuss the likely course and any need for follow-up during your consultation rather than to offer a fixed promise.
Recovery is generally described as minimal. Because the procedure uses a same-day autologous protocol, most patients can typically resume normal daily activities shortly afterward, though temporary discomfort at the blood-draw or treatment site may occur. As with any procedure, follow the clinic's specific aftercare instructions.
A grounded way to approach any regenerative treatment is to separate what is documented from what is hoped for. What is documented here is the process: your own blood is collected, processed the same day without cell culture, and administered under physician supervision. What is not established is any guaranteed clinical benefit, and the honest position, reflected by both the clinic and the FDA cautions above, is that outcomes vary and are not promised. Bringing a written list of questions to your consultation, including what the physician expects in your specific case and what follow-up may be advised, is one of the most useful things you can do.
Possible risks and side effects
No injection-based procedure is risk-free. Commonly described, usually temporary, effects include redness, swelling, bruising, tenderness or discomfort at the blood-draw or injection site. As with any injection, infection or bleeding is possible, although uncommon when proper sterile technique is used. The broader FDA cautions above are also relevant when considering any regenerative treatment. Discuss your individual risks and any underlying conditions with the physician before proceeding. You can also review the clinic's patient reviews for context, keeping in mind that individual experiences vary and are not a substitute for medical advice.
How New M-Cell Compares With Other Options
Maison de M Clinic lists several alternative regenerative or aesthetic approaches that a physician might discuss depending on your goals, including platelet-rich plasma (PRP), exosome-based therapies, collagen-stimulating injectables, skin boosters, and energy-based rejuvenation procedures. New M-Cell may also be incorporated into a broader, individualized plan alongside other physician-recommended treatments. None of these comparisons implies that any option is superior; the appropriate choice, if any, is a clinical decision made with your physician. Cost is not published here and is confirmed at consultation.
It is also worth noting that Dr. Choi Chang Won, Chief Medical Director at Maison de M Clinic, is a member of the Korean Association of Stem Cell Therapy. Membership in a professional association reflects involvement in the field; it is not, in itself, a claim about the effectiveness of any particular treatment.
The Bottom Line
- New M-Cell is described by Maison de M Clinic as an autologous, same-day, blood-derived regenerative treatment that uses the patient's own minimally manipulated blood cells, prepared without laboratory cell culture.
- A 510(k)-cleared device may be used for processing, but that clears the equipment; it does not make the therapy FDA-approved for effectiveness. Such regenerative treatments are generally not FDA-approved for efficacy.
- The FDA cautions consumers about unapproved regenerative and stem-cell products, and the clinic itself states that no guarantee of therapeutic outcome or disease-specific benefit is made.
- Recovery is generally minimal, but temporary redness, swelling, bruising or tenderness, and the rare risks of infection or bleeding, are possible with any injection.
- Candidacy, session plans and cost are individualized and confirmed only after a physician consultation at the Seoul clinic.
Frequently Asked Questions
**What is New M-Cell?**Maison de M Clinic describes New M-Cell as an autologous blood-cell regenerative treatment that uses cells and biologically active components from the patient's own blood, processed on the same day without cell culture and administered as part of an individualized regenerative protocol.
**Is New M-Cell FDA-approved?**The processing may use an FDA 510(k)-cleared device, which is a clearance of the equipment. That does not mean the therapy is FDA-approved for effectiveness. Autologous blood-derived regenerative aesthetic treatments are generally not FDA-approved for efficacy, and the FDA cautions consumers about unapproved regenerative products.
**Who is a good candidate?**The clinic describes it as potentially appropriate for people seeking an autologous regenerative treatment using their own blood-derived components, with eligibility determined only after a physician reviews your health, medical history and goals.
**Who should avoid or postpone treatment?**People with active infections, uncontrolled medical conditions, significant blood disorders or other contraindications identified during evaluation may not be suitable. Final eligibility is decided by the treating physician after a comprehensive consultation.
**Is the procedure painful, and how long does it take?**Discomfort is usually limited to the blood draw and injection, and local numbing may be used depending on the area. It is generally a same-day treatment, including consultation, collection, processing and administration; exact timing depends on the individual plan.
**When will I see results?**Any response is described as developing gradually and varying by individual, indication and biological response. The clinic states that no specific therapeutic outcome can be guaranteed, and the physician will discuss what to expect and any follow-up during consultation.
**What are the possible side effects?**Temporary redness, swelling, bruising, tenderness or discomfort at the blood-draw or injection site may occur. As with any injection, infection or bleeding is possible though uncommon with proper technique. Report persistent or unusual symptoms to the medical team.
**How much does New M-Cell cost at Maison de M Clinic?**Cost is not published here and depends on the individualized treatment plan. Pricing and specifics are confirmed at consultation, which you can request through the clinic's contact page.
This article is for general informational purposes and does not constitute individualized medical advice. Consult a qualified physician about your specific condition.
References
- Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes — U.S. FDA
- Patient and Consumer Warning About Potential Serious Risks of Harm Following Use of Unapproved Products from Human Cells or Tiss
- Dermal Fillers (Soft Tissue Fillers) — U.S. FDA
- Stem Cells — MedlinePlus, U.S. National Library of Medicine
More Clinical Articles
Continue reading physician-informed guides on non-surgical lifting, skin texture renewal, and aftercare in Seoul.
CellExosome BLACKLABEL: Exosome Skin Care at Maison de M
An evidence-cautious look at CellExosome BLACKLABEL exosome skin treatments at Maison de M Clinic in Seoul, and why exosome products are not FDA-approved.
Learn More
Sofwave and Thermage for Deeper Skin Tones: A Guide
How energy-based lifting devices Sofwave and Thermage work, and how clinicians tailor treatment for Latina, Mediterranean and deeper skin tones.
Learn More
Pting Laser vs CO2 Laser: Pain Scores and Recovery Benchmarks from KR
Pting Laser vs CO2 Laser: Pain Scores and Recovery Benchmarks from KR
Learn More